Program

Reception desk / Imagine entrance

Oral presentations / auditorium

Poster presentations / 7th floor

Coffee and lunch breaks / 6th floor

    • 9:00 AM Corentin Le Floc'h

      Autosomal dominant ZAP70 deficiency

    • 9:15 AM Juan Eduardo Montero-Hernández

      CCL2 chemokine follows a complex bi-temporal secretion pattern for local attraction during IgE-mediated mast cell activation

    • 9:30 AM Marco M Rodari

      Human integrin alpha-V deficiency skews B cell responses toward extra-follicular pathways in IgE-mediated allergy

    • 9:45 AM Aldevron

    • 10:00 AM Lea Nabhan

      A genome-wide CRISPR interference (CRISPRi) screen to identify essential V(D)J/DNA repair genes

    • 10:15 AM Boris Bessot

      Gene therapy for Artemis-SCID patients: preliminary results of the French ARTEGENE phase I/II clinical trial

Coffee break / 30 minutes

    • 11:00 AM Christin Weissleder

      Parkinson’s Disease and the Gut-Brain Axis: How Microbial Metabolites and Genetic Risk Drive Immune Cell Dysfunction

    • 11:15 AM Zoéline Mars

      DDX41, a gene associated with predisposition to hematological malignancies, is responsible for syndromic retinal dystrophy

    • 11:30 AM Joran Martin

      Primary cilium drives inflammatory response associated with uropathogenic bacteria infection and kidney obstruction damage

    • 11:45 AM ProteinTech

    • 12:00 AM Bianca Ionela Slivinschi

      A novel iPSC-derived Gut-on-Chip model for studying Parkinson’s Disease pathology

    • 12:15 AM Joël Boivin

      Generation of new zebrafish models via precise genome editing

Lunch break / 12:30 PM - 01:30 PM

    • 01:30 PM Lucile Marchal

      Multi-omic analysis of cutaneous squamous cell carcinoma in patients with Recessive Dystrophic Epidermolysis Bullosa identifies new therapeutic targets

    • 01:45 PM Romain Nicolle

      Graph neural networks reveal digenic disease candidates through biological network analysis

    • 02:00 PM Adrien Schvartz

      Specific Transcriptomic Signature in Oligoarticular JIA Patients Who Will Not Respond to Anti-TNFα Treatment

    • 01 Khawla Aljabali
      Multimodal Brain Imaging in Autism Spectrum Disorders in Patients with SHANK3 mutations

    • 02 Huyen Augis Chu
      Sample clearing and 3D imaging

    • 03 Antoine Gonde
      Germline variants in JAK3 and chronic active EBV infection associated with auto-inflammation and skin disease

    • 04 Elena Retana
      Development of prime editing strategies for alpha-thalassemia

    • 05 Mathilde Nesson-Dauphin
      Cellular and zebrafish approaches to model a neurodevelopmental disorder caused by CACNA1G mutations

    • 06 Marine Gloanec
      Kinetics of ventricular growth defects in the heterotaxy syndrome

    • 07 Judith Beaux
      Reln sources in cortical development and neurodevelopmental disorders

    • 08 Candice Moncler
      Missense variants in the second transmembrane domain of TMEM17 disrupt its stability and function and lead to a wide phenotypic spectrum of ciliopathies

    • 09 Gwenaëlle Laurent
      Unraveling the pathophysiology of TANGO2 disease

    • 10 Mohamed Kehili
      The role of mitochondrial unfolded protein response activation over neuronal functions and glial reactivity

    • 11 Malena Pérez Lorenzo
      A novel form of inherited human RelB deficiency

    • 12 Alice Lecomte
      Atlas of human cardiac development during the embryonic period

    • 13 Lucie Day
      Role of ADAR1 and RNA editing in peripheral myelin maintenance

    • 14 Janja Kovacic
      Enhanced TLR7 and TLR9 Signaling in Plasmacytoid Dendritic Cells Expressing UNC93B1 Mutations

    • 15 Maeva Hubert
      Extracellular matrix asymmetries during heart looping

    • 16 Carmela Giachino
      Dissecting the role of LRRK2 in intercellular communication using iPSC-derived neuron-glia tricultures

    • 17 Hariam Raji
      A multi-organoid microfluidic approach to investigate the gut-brain axis in Parkinson’s disease

Coffee break / 15 minutes

    • Florence Gazeau

      Nanomedicine approaches for immuno and biotherapies

      Physicist by training, Florence Gazeau is Research Director (DR) at CNRS. In 2024, she was awarded the CNRS silver medal for her fundamental and applied research on magnetic nanoparticles for imaging and precision therapy. Very recently, she became member of the French Academy of Sciences. Florence Gazeau is now head of the NABI laboratory (INSERM, CNRS, Université Paris-cité), at the forefront of research into nanomedicine and extracellular vesicles.

  • Conclusion by Bana Jabri and prizes presented by Nadine Cerf-Bensussan

  • 7th floor